Koumprentziotis IA, Rompoti N, Stefanaki I, Vavouli C, et al. Single-center experience with bimekizumab in psoriasis patients with previous exposure to interleukin-17 inhibitors. Int J Dermatol 2024 Dec 30. doi: 10.1111/ijd.17630.
PMID: 39740018